Cargando…
Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
Nuclear KIFC1 (nKIFC1) predicts worse outcomes in breast cancer, but its prognostic value within racially distinct triple-negative breast cancer (TNBC) patients is unknown. Thus, nKIFC1 expression was assessed by immunohistochemistry in 163 African American (AA) and 144 White TNBC tissue microarrays...
Autores principales: | Ogden, Angela, Garlapati, Chakravarthy, Li, Xiaoxian (Bill), Turaga, Ravi Chakra, Oprea-Ilies, Gabriela, Wright, Nikita, Bhattarai, Shristi, Mittal, Karuna, Wetherilt, Ceyda Sönmez, Krishnamurti, Uma, Reid, Michelle D., Jones, Mildred, Gupta, Meenakshi, Osan, Remus, Pattni, Sonal, Riaz, Ansa, Klimov, Sergey, Rao, Arundhati, Cantuaria, Guilherme, Rida, Padmashree C. G., Aneja, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316996/ https://www.ncbi.nlm.nih.gov/pubmed/28218233 http://dx.doi.org/10.1038/srep42289 |
Ejemplares similares
-
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
por: Mittal, Karuna, et al.
Publicado: (2016) -
Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations
por: Wright, Nikita, et al.
Publicado: (2017) -
Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015) -
KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014) -
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
por: Bhattarai, Shristi, et al.
Publicado: (2019)